BNET -- Allergan CEO David Pyott could get a $15.7 million change-of-control bonus if he says yes to GlaxoSmithKline’s alleged interest in buying his company.
BNET -- Allergan CEO David Pyott could get a $15.7 million change-of-control bonus if he says yes to GlaxoSmithKline’s alleged interest in buying his company.
